Concepedia

Weiping Deng

WD

68

Publications

5.9K

Citations

32

H-Index

2005

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Brigham and Women's Hospital

Duke Medical Center

Yunnan Agricultural University

Baylor College of Medicine

Weiping Deng is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

2005–2025

68

Publications

68

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al. · Science · 2022 · 1.2K citations · Full text

, , +9

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Andreas Hochhaus, Giuseppe Saglio, Timothy P. Hughes et al. · Leukemia · 2016 · 841 citations · Full text

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 647 citations · Full text

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Andreas Hochhaus, Tamás Masszi, Francis J. Giles et al. · Leukemia · 2017 · 286 citations · Full text

Whole-genome resequencing of 472 Vitis accessions for grapevine diversity and demographic history analyses

Zhenchang Liang, Shengchang Duan, Jun Sheng et al. · Nature Communications · 2019 · 210 citations · Full text

Rows per page

1–5 of 68